Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Int J Mol Sci ; 21(16)2020 Aug 08.
Article in English | MEDLINE | ID: mdl-32784509

ABSTRACT

Birch pollen allergy is among the most prevalent pollen allergies in Northern and Central Europe. This IgE-mediated disease can be treated with allergen immunotherapy (AIT), which typically gives rise to IgG antibodies inducing tolerance. Although the main mechanisms of allergen immunotherapy (AIT) are known, questions regarding possible Fc-mediated effects of IgG antibodies remain unanswered. This can mainly be attributed to the unavailability of appropriate tools, i.e., well-characterised recombinant antibodies (rAbs). We hereby aimed at providing human rAbs of several classes for mechanistic studies and as possible candidates for passive immunotherapy. We engineered IgE, IgG1, and IgG4 sharing the same variable region against the major birch pollen allergen Bet v 1 using Polymerase Incomplete Primer Extension (PIPE) cloning. We tested IgE functionality and IgG blocking capabilities using appropriate model cell lines. In vitro studies showed IgE engagement with FcεRI and CD23 and Bet v 1-dependent degranulation. Overall, we hereby present fully functional, human IgE, IgG1, and IgG4 sharing the same variable region against Bet v 1 and showcase possible applications in first mechanistic studies. Furthermore, our IgG antibodies might be useful candidates for passive immunotherapy of birch pollen allergy.


Subject(s)
Allergens/immunology , Betula/chemistry , Hypersensitivity/immunology , Immunoglobulin E/immunology , Immunoglobulin G/immunology , Pollen/chemistry , Rhinitis, Allergic, Seasonal/immunology , Antibody Specificity/immunology , Basophils/physiology , Cell Degranulation/physiology , Endocytosis , Humans , Immunoglobulin E/blood , Monocytes/metabolism , Recombinant Proteins/metabolism , U937 Cells , Up-Regulation
3.
Bioelectrochemistry ; 134: 107495, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32182566

ABSTRACT

Irreversible electroporation holds great potential for cell-specific lysis due to the size-dependent susceptibility of cells to externally imposed electric fields. Previous attempts at selective cell lysis lead to significant overlap between affected populations and struggle with inconsistent biological outcome. We propose that charge transfer at the electrode-liquid interface is responsible by inducing multifactorial effects originating from both the electric field and electrochemical reactions. A promising remedy is the coating of electrodes with a high-k dielectric layer. The resulting capacitive coupling restores the selective potential of electric field mediated lysis in a microfluidic setup. Initial experiments show the consistent depletion of erythrocytes from whole blood while leaving leukocytes intact. The same is true for the reproducible and selective depletion of Jurkat and MCF-7 cells in a mixture with leukocytes. Unexpectedly, the observed order of lysis cannot be correlated with cell size. This implies that the cellular response to capacitive coupling features a selective characteristic that is different from conventional lysis configurations.


Subject(s)
Electric Capacitance , Electroporation/methods , Cell Death , Cell Membrane/metabolism , Humans , Jurkat Cells , Leukocytes/cytology , MCF-7 Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...